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ABSTRACT
Two commercially available enzyme immunoas-
says (EIAs), IDEIA and Ridascreen, for norovirus
antigen detection were evaluated with 117 faecal
samples from hospitalised children with acute
gastroenteritis. Eighteen of 39 samples positive by
RT-PCR were characterised by sequence analysis,
and 17 of these were related to norovirus geno-
group II. When compared with RT-PCR, the
sensitivity and speciﬁcity values were 76.9%
and 85.9%, respectively, for the IDEIA assay,
and 59.0% and 73.1%, respectively, for the Rid-
ascreen assay. The sensitivity and speciﬁcity of
both EIA tests require improvement, but they
could both eventually be of use in the diagnosis of
norovirus diarrhoea in clinical laboratories.
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The family Caliciviridae contains two viruses that
infect humans: norovirus (NoV) and sapovirus
(SV). Norovirus is the leading cause of epidemic
non-bacterial outbreaks of gastroenteritis [1], and
is also an important cause of infantile sporadic
acute gastroenteritis [2–4].Norovirus genogroups I
and II, comprising at least 29 different genetic
clusters, contain most of the strains that infect
humans [5]. Currently, RT-PCR is the main diag-
nostic tool for human Caliciviridae infections and
is considered to be the diagnostic standard [6].
Commercial enzyme immunoassays (EIAs) have
recently been developed, but limited data concern-
ing their performance are available. In previous
studies, the IDEIA NVL assay (DakoCytomation,
Ely, UK) was reported to have a sensitivity of
39)55.5% and a speciﬁcity of 98.3)100% in com-
parison with RT-PCR [7,8]. The aim of the present
study was to evaluate the IDEIA NVL assay
together with a second assay, Ridascreen NLV
(R-BioPharm, Darmstadt, Germany), for their abil-
ity to detect NoV antigen in faecal samples.
The study was performed with children aged
< 5 years with a clinical diagnosis of acute
gastroenteritis, hospitalised in Severo Ochoa
Hospital, Madrid, Spain between 1 October 2002
and 1 April 2004. Stool specimens were collected
within 24)48 h of admission and were stored at
4C. All samples were screened for bacterial
pathogens, rotaviruses, adenoviruses and astro-
viruses. A subset of 117 samples negative for
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these pathogens was tested for Caliciviridae by
RT-PCR and the IDEIA NVL and Ridascreen NLV
EIAs. Both EIAs use monoclonal antibodies
speciﬁc for the capsid antigens of NoV gen-
ogroups I and II; in addition, the IDEIA assay
differentiates the two genogroups.
For the RT-PCR assay (One-Step RT-PCR kit;
QIAGEN, Valencia, CA, USA), RNA was ﬁrst
extracted using the guanidine thiocyanate meth-
od, as described previously [9], and the Rnaid
Spin Kit (Qbiogen, Inc., Irvine, CA, USA). Sam-
ples were tested initially with the JV12y-JV13i
primer pair, which detects the majority of known
strains of the NoV genus [10]. Samples that tested
negative were then analysed with the p289-p290
primer pair, which detects NoV and SV [11]. PCR
products were analysed by electrophoresis in
agarose 2% w ⁄v Tris-borate-EDTA gels, and were
visualised by UV illumination after staining with
ethidium bromide. In order to detect possible
inhibitors, RNA of a known NoV-positive sample
was added to the RT-PCR mixture. A tube
containing the RT-PCR mixture without an RNA
sample was used as a negative control.
Eighteen RT-PCR-positive specimens were
characterised genetically, following puriﬁcation
of the PCR products with a QIAquick PCR
Puriﬁcation Kit (QIAGEN), by sequencing the
partial polymerase gene sequences with an ABI
PRISM BigDye Terminator Cycle Sequencing
Ready Reaction Kit (Applied Biosystems, Foster
City, CA, USA) and an ABI 3700 automated
sequencer (Applied Biosystems). A multiple-
sequence alignment was generated from the
consensus sequence of each of the isolates and
ten reference strains (X86557, U46500, U07611,
AX348232, U22498, X81879, U97072, U04469,
M87661 and L07418) by the CLUSTALX 1.8
method. The partial polymerase gene sequences
were analysed further with the MEGA 3 analyt-
ical package using the neighbour-joining [12] and
Kimura 2p algorithm methods [13] to assess
phylogenetic relationships in comparison with
the NoV reference strains. Statistical comparisons
were calculated using a standard formula [14],
with RT-PCR as the reference method. The kappa
coefﬁcient was also calculated, with values of
‡ 0.6 denoting that agreement between assays was
not random [15].
In total, 642 faecal samples from hospitalised
children were included in the study. No patho-
gens were detected in 169 (25.7%) specimens. Of
these, 117 samples were tested with the RT-PCR,
IDEIA NVL and Ridascreen NLV assays. Thirty-
nine samples were positive by RT-PCR (33 with
the JV12y-JV13i and six with the p289-p290
primer pairs). Overall, 77 (65.8%) samples
yielded concordant results with the three meth-
ods, whereas 40 (34.2%) samples yielded discord-
ant results (Table 1). The sensitivity, speciﬁcity,
positive and negative predictive values, agree-
ment and kappa index values are shown in
Table 2. Genotyping and sequence analysis were
performed on 18 of 39 RT-PCR-positive samples
for which there was an adequate amount of
material. Of these 18 samples, one contained SV
and 17 contained NoV (13 Lorsdale (12 nvGII.4
and one Camberwell), one Leeds and three
GGIIb). The IDEIA assay failed to detect one of
the 17 NoV strains (the sample containing the
Leeds strain), whereas the Ridascreen assay failed
to detect ﬁve samples (one Leeds, two GGIIb and
two Lorsdale strains).
Overall, the sensitivity (76.9%) of the IDEIA
assay in the present study, compared with RT-
PCR, was higher than in previous studies [7,8],
but the speciﬁcity was lower (85.9% vs. 98.3% [7]
and 100% [8]). The Ridascreen assay had lower
sensitivity (59.0%) and speciﬁcity (73.0%) than in
previous studies [16, 17]. The 12 samples positive
Table 2. Statistical comparisons with RT-PCR as the ref-
erence standard
Parameter
Test method
IDEIA Ridascreen
Sensitivity 76.9% 59.0%
Speciﬁcity 85.9% 73.1%
PPV 73.2% 52.3%
NPV 88.2% 78.1%
Agreement 82.9% 68.4%
Kappa index 0.6203 0.3103
PPV, positive predictive value; NPV, negative predictive value.
Table 1. Comparison of the results obtained from the
enzyme immunoassay and RT-PCR assays
IDEIAa Ridascreen RT-PCR
No. of samples
(total = 117)
n (%)
+ + + 22 (18.8)
+ + ) 9 (7.7)
+ ) + 8 (6.8)
) + + 1 (0.8)
) ) + 8 (6.8)
) + ) 12 (10.2)
+ ) ) 2 (1.7)
) ) ) 55 (47.0)
aAll positive IDEIA results corresponded with norovirus genogroup II.
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only by the Ridascreen assay showed absorbance
units at least 1.5-fold greater than the cut-off
value. Previous studies have also encountered
similar false-positive results with this EIA method
[16]. The nine samples that were negative by
RT-PCR, but positive by both EIAs, also exhibited
high absorbance values. The possibility of false-
negative RT-PCR results for these samples cannot
be excluded, and may be associated with factors
that might affect the sensitivity of the RT-PCR
assay, e.g., the instability of viral RNA, the
presence of PCR inhibitors in faecal samples,
and the genetic diversity of the NoV genomes [7].
In conclusion, neither of the EIA assays ana-
lysed in this study was sufﬁciently sensitive to be
useful as a sole diagnostic method for sporadic
cases of NoV-associated acute gastroenteritis, and
neither can substitute for the RT-PCR method.
The lack of a simple test has limited the routine
diagnosis of NoV diarrhoea, and RT-PCR is
unavailable in many clinical laboratories [7].
Although the EIA method shows some promising
results, its sensitivity must be increased for these
assays to become useful as a primary tool for the
detection of NoV diarrhoea in clinical laborator-
ies.
ACKNOWLEDGEMENTS
This study was supported, in part, by the Instituto de Salud
Carlos III (grant no. MPY 1176 ⁄ 04). The authors thank V.
Montero and A. Potente for technical assistance. We are also
grateful to the Genomic Unit for extensive sequencing work,
and to M. L. Marı´ for critical reading of the manuscript.
REFERENCES
1. Frankhauser RL, Monroe SS, Noel JS et al. Epidemiologic
and molecular trends of ‘Norwalk-like viruses’ associated
with outbreaks of gastroenteritis in the United States.
J Infect Dis 2000; 186: 1–7.
2. Kirkwood CD, Clark R, Bogdanovic-Sakran N, Bishop RF.
A 5-year study of the prevalence and genetic diversity of
human caliciviruses associated with sporadic cases of
acute gastroenteritis in young children admitted to hos-
pital in Melbourne, Australia (1988–2002). J Med Virol 2005;
77: 96–101.
3. Roma´n E, Negredo A, Dalton RM, Wilhelmi I, Sa´nchez-
Fauquier A. Molecular detection of human calicivirus
among Spanish children with acute gastroenteritis. J Clin
Microbiol 2002; 40: 3857–3859.
4. Zintz C, Bok K, Parada E et al. Prevalence and genetic
characterisation of caliciviruses among children hospital-
ised for acute gastroenteritis in the United States. Infect
Genet Evol 2005; 5: 281–290.
5. Ando T. Genetic classiﬁcation of ‘Norwalk-like Viruses’.
J Infect Dis 2000; 181 (suppl): 336S–348S.
6. Green J, Gallimore CI, Norcott JP, Lewia D, Brown DWG.
Broadly reactive reverse transcriptase polymerase chain
reaction (RT-PCR) for the diagnosis of SRSV-associated
gastroenteritis. J Med Virol 1995; 47: 392–398.
7. Richards AF, Lopman B, Gunn A et al. Evaluation of
commercial EIA for detecting Norwalk-like virus antigen
in faeces. J Clin Virol 2003; 26: 109–115.
8. Burton-MacLeod JA, Kane EM, Beard RS, Hadley LA,
Glass RI, Ando T. Evaluation and comparison of two
commercial enzyme –linked immunosorbent assay kits for
detection of antigenically diverse human noroviruses in
stool samples. J Clin Microbiol 2004; 42: 2587–2595.
9. Wilhelmi I, Mier C, Roma´n E, Colomina J, Prat J, Sa´nchez-
Fauquier A. Epidemiologı´a molecular de rotavirus en nin˜os
espan˜oles. Enferm Infecc Microbiol Clin 1999; 17: 509–514.
10. Vennema H, de Bruin E, Koopmans M. Rational optimi-
sation of generic primers used for Norwalk-like virus
detection by reverse transciptase polymerase chain reac-
tion. J Clin Virol 2002; 25: 233–235.
11. Jiang X, Huang PW, Zhong WM et al. Design and evalu-
ation of a primer pair that detects both Norwalk- and
Sapporo-like caliciviruses by RT-PCR. J Virol Meth 1999;
83: 145–154.
12. Suzuki Y, Katayama K, Fukushi S et al. Slow evolutionary
rate of GB virus C ⁄hepatitis G virus. J Mol Evol 1999; 48:
383–389.
13. Kimura M. A simple method for estimating evolutionary
rates of base substitution through comparative studies of
nucleotide sequences. J Mol Evol 1980; 16: 111–120.
14. Constantine LT, Lana DP. Immunoassays for the diagnosis
of infectious diseases. In: Baron EJ, Jorgensen JH, Pfaller
M, Yolken RH, eds.,Manual of clinical microbiology, 8th edn.
Washington DC: ASM Press, 2003; 218–233.
15. Landis JR, Koch GG. The measurement of observer
agreement for categorical data. Biometrics 1977; 33: 150–
174.
16. Schmid M, Oehme R, Schalasta G, Brockmann S, Kimmig
P, Enders G. Fast detection using a real-time PCR assay
and automated sample preparation. BMC Infect Dis 2004;
4: 15.
17. Dimitriadis A, Marshall JA. Evaluation of a commercial
enzyme immunoassay for detection of norovirus in out-
break specimens. Eur J Clin Microbiol Infect Dis 2005; 24:
615–618.
Research Notes 343
 2006 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 13, 316–346
